Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090359 · ClinicalTrials.gov registry record · Phase 4
Dual Mobility Acetabular Cups in Revision TJA
A Phase 4 study of Dislocation, Hip, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 322
- Enrollment target
- 2
- Study locations
NCT04090359: Recruiting Phase 4 study of Dislocation, Hip, sponsored by Rush University Medical Center.
NCT04090359 is a Phase 4 study of Dislocation, Hip that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 322 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (38% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04090359, a Phase 4 study of Dislocation, Hip, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 322 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in revision THA will be associated with a lower dislocation rate in the first year following surgery.
Primary Outcome
The rate of prosthetic dislocation between the two cohorts will be measured at standard postoperative clinic visits
Conditions Studied
Interventions
- DEVICE Dual Mobility Implant
- DEVICE Conventional, single-bearing implant
Study Locations (2)
New York
- New York University Medical Center - New York
Pennsylvania
- Rothman Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2036-12-01 |
| Phase | Phase 4 |
What NCT04090359 shows while recruiting
NCT04090359 is an interventional study that assigns participants to a tested intervention. The registered 322 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Dislocation, Hip appearing as the primary indexed condition, and to 2 interventions - of which Dual Mobility Implant is the first listed.
NCT04090359 reports a single indexed study location in New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04090359 about?
NCT04090359 is a clinical study titled "Dual Mobility Acetabular Cups in Revision TJA". The aim of this study is to the compare clinical outcomes of patients undergoing a revision total hip arthroplasty (THA) with the use of a dual mobility bearing versus a single bearing design with the use of a large femoral head (36mm or 40mm). We hypothesize the use of dual-mobility components in r...
What is the current status of trial NCT04090359?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 322 participants. The study started on 2017-09-01. Estimated completion is 2036-12-01.
What conditions does trial NCT04090359 study?
This clinical trial studies the following conditions: Dislocation, Hip.
What interventions are being tested in trial NCT04090359?
The interventions under investigation include: Dual Mobility Implant (DEVICE), Conventional, single-bearing implant (DEVICE).
Who is sponsoring clinical trial NCT04090359?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04090359 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dislocation, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04090359's enrollment target sits among peer trials
322 257th of 2000 higher than 1,743 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04924075 · 322 participants · Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- NCT03715933 · 321 participants · Phase 1
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- NCT05922878 · 321 participants · Phase 2
Study of ALTO-300 in MDD
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI